keratinocyte-derived chemokines

Networked: 5 relevant articles (0 outcomes, 0 trials/studies)

1.	Disease Progression 07/01/2011 - "Time-dependent increases in cytokines and chemokines, including tumor necrosis factor-α, interleukin (IL)-1β, IL-6, IL-10, keratinocyte-derived chemokines and macrophage inflammatory protein-2, were observed in the serum and liver tissue of K1- and K2-infected mice, and severe disease progression manifesting as microabscesses was also identified. "
2.	Vitiligo 01/01/2017 - "Keratinocyte-Derived Chemokines Orchestrate T-Cell Positioning in the Epidermis during Vitiligo and May Serve as Biomarkers of Disease."
3.	Psoriasis (Pustulosis Palmaris et Plantaris) 09/01/2021 - "Furthermore, bath PUVA therapy reduced the secretion of keratinocyte-derived chemokines that induce the migration of immune cells important for psoriasis pathogenesis, partly revealing the mechanism of the therapeutic activity."
4.	Hyperalgesia 01/01/2016 - "Atenolol Reduces Leishmania major-Induced Hyperalgesia and TNF-α Without Affecting IL-1β or Keratinocyte Derived Chemokines (KC)."
5.	Bronchiolitis Obliterans Syndrome 01/01/2020 - "Similarly, in chronic graft-versus-host disease, allogenic IFNγ-producing Th1/Tc1 and IL-17-producing Th17/Tc17 cells are recruited by keratinocyte-derived chemokines and accumulate in the skin. "

1.	Chemokines
2.	Interleukin-10 (Interleukin 10)
3.	Cytokines
4.	Interleukin-6 (Interleukin 6)
5.	Biomarkers (Surrogate Marker)
6.	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
7.	Interleukins
8.	Atenolol (Tenormin)

1.	PUVA Therapy